NCT00214825View on ClinicalTrials.gov

Aldosterone and Vascular Disease in Diabetes Mellitus

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Diabetes MellitusEndothelial DysfunctionAlbuminuria
Interventions
DRUG

eplerenone

50 mg daily for 6 weeks with placebo

DRUG

Hydrochlorothiazide

HCTZ 12.5 mg with potassium (10 mEq) daily for 6 weeks

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Brigham and Women's Hospital

OTHER

NCT00214825 - Aldosterone and Vascular Disease in Diabetes Mellitus | Biotech Hunter | Biotech Hunter